Homelessness and High-Dosage Buprenorphine Misuse

References

• Baker A., Kochan N., Dixon J., Wodak A., Heather N. HIV risk-taking behaviour among injecting drug users currently, previously and never enrolled in methadone treatment. Addiction 1995; 90: 545–554
   PubMed Web of Science ®Google Scholar
• Ball J. C., Lange W. R., Myers C. P., Friedman S. R. Reducing the risk of AIDS through methadone maintenance treatment. J. Health Soc. Behav 1998; 29: 214–226
   Google Scholar
• Bell D. C., Montoya I. D., Atkinson J. S. Partner concordance in reports of joint risk behaviors. J. Acquir. Immune. Defic. Syndr 2000; 25: 173–181
   PubMed Web of Science ®Google Scholar
• De Irala J., Bigelow C., McCusker J., Hindin R., Zheng L. Reliability of self-reported human immunodeficiency virus risk behaviors in a residential drug treatment population. Am. J. Epidemiol 1996; 143: 725–732
   PubMed Web of Science ®Google Scholar
• Decocq G., Fremaux D., Smail A., Compagnon M., Andrejak M. Local complications after intravenous injection of dissolved tablets of buprenorphine (letter). Presse. Med 1997; 26: 1433
   PubMedGoogle Scholar
• Faroqui M. H., Cole M., Curran J. Buprenorphine, benzodiazepines and respiratory depression. Anaesthesia 1983; 38: 1002–1003
   PubMedGoogle Scholar
• Farrell M., Ward J., Mattick R., Hall W., Stimson G. V., Des J. D., Gossop M., Strang J. Methadone maintenance treatment in opiate dependence: a review (see comments). BMJ 1994; 309: 997–1001
   PubMed Web of Science ®Google Scholar
• Forrest A. L. Buprenorphine and lorazepam. Anaesthesia 1983; 38: 598
   PubMedGoogle Scholar
• Gleghorn A. A., Marx R., Vittinghoff E., Katz M. H. Association between drug use patterns and HIV risks among homeless, runaway, and street youth in northern California. Drug Alcohol Depend 1998; 51: 219–227
   PubMed Web of Science ®Google Scholar
• Goldstein M. F., Friedman S. R., Neaigus A., Jose B., Ildefonso G., Curtis R. Self-reports of HIV risk behavior by injecting drug users: are they reliable?. Addiction 1995; 90: 1097–1104
   PubMed Web of Science ®Google Scholar
• Harris D. S., Jones R. T., Welm S., Upton R. A., Lin E., Mendelson J. Buprenorphine and naloxone co-administration in opiate-dependent patients stabilized on sublingual buprenorphine. Drug Alcohol Depend 2000; 61: 85–94
   PubMed Web of Science ®Google Scholar
• Haut Comité de la Santé Publique. “La précarité de l'habitat et le cadre de vie.”. La progression de la précarite en France et ses effets sur la santé “Housing precariousness and its implications on lifestyle”in Precariousness spread in France and its deleterious effects on healthENSP ed., Haut Comité de la Santé Publique. Ministére de l'Emploi et de la Solidarité, Paris 1998; pp. 262–269
   Google Scholar
• Jain P. N., Shah S. C. Respiratory depression following combination of epidural buprenorphine and intramuscular ketorolac. Anaesthesia 1993; 48: 898–899
   PubMedGoogle Scholar
• Johnson T. P. Alcohol and drug use among displaced persons: an overview. Subst. Use Misuse 1996; 31: 1853–1889
   PubMed Web of Science ®Google Scholar
• Lewis J. W. Buprenorphine. Drug Alcohol Depend 1985; 14: 363–372
   PubMed Web of Science ®Google Scholar
• Loo H., Laqueille X., Remi P., Bayle F., Olie J. P. Treatment of heroin addicts by substitution with methadone. Importance, limits and experience in France. Bull. Acad. Natl. Med. 1993; 177: 1315–1325
   PubMedGoogle Scholar
• McElrath K., Chitwood D. D., Griffin D. K., Comerford M. The consistency of self-reported HIV risk behavior among injection drug users. Am. J. Public Health 1994; 84: 1965–1970
   PubMed Web of Science ®Google Scholar
• Mendelson J., Jones R. T., Welm S., Baggott M., Fernandez I., Melby A. K., Nath R. P. Buprenorphine and naloxone combinations: the effects of three dose ratios in morphine-stabilized, opiate-dependent volunteers. Psychopharmacology (Berl) 1999; 141: 37–46
   PubMed Web of Science ®Google Scholar
• Morrison C. S., McCusker J., Stoddard A. M., Bigelow C. The validity of behavioral data reported by injection drug users on a clinical risk assessment. Int. J. Addict 1995; 30: 889–899
   PubMed Web of Science ®Google Scholar
• O'Connor P. G., Fiellin D. A. Pharmacologic treatment of heroin-dependent patients. Ann. Intern. Med. 2000; 133: 40–54
   PubMed Web of Science ®Google Scholar
• Obadia Y., Perrin V., Feroni I., Vlahov D., Moatti J. P. Injecting misuse of buprenorphine among French drug users. Addiction 2001; 96: 267–272
   PubMed Web of Science ®Google Scholar
• Thirion X., Barrau K., Micallef J., Haramburu F., Lowenstein W., Sanmarco J. L. Maintenance treatment for opioid dependence in care centers: the OPPIDUM program of the Evaluation and Information Centers for Drug Addiction. Ann. Med. Interne(Paris) 2000; 151(Suppl. A)A10–A17
   PubMedGoogle Scholar
• Tracqui A., Kintz P., Ludes B. Buprenorphine-related deaths among drug addicts in France: a report on 20 fatalities. J. Anal. Toxicol 1998; 22: 430–434
   PubMed Web of Science ®Google Scholar
• Vidal-Trecan G., Boissonnas A., avec la collaboration de, Varescon I., Nabet N., Couzigou C., Blanchon T. Usagers de drogues injectables et buprénorphine haut dosage: Analyse des déviations de son utilisation (Injection drug users and sublingual buprenorphin tablets: misuse analysis). OFDT, Paris 2001
   Google Scholar
• Vidal-Trecan G., Coste J., Varescon-Pousson I., Reboul-Marty J., Christoforov B., Boissonnas A. Patterns of sexual and injecting risk behaviours in French intravenous drug users not reporting HIV and hepatitis C virus seropositivities. Addiction 1998; 93: 1657–1668
   PubMed Web of Science ®Google Scholar
• Wenzel S. L., Koegel P., Gelberg L. Access to substance abuse treatment for homeless women of reproductive age. J. Psychoactive Drugs 1996; 28: 17–30
   PubMed Web of Science ®Google Scholar